Lack of human papillomavirus in pterygium of Chinese patients from Taiwan.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. The role of HPV in the etiopathogenesis of pterygium and the relationship with recurrence.International ophthalmology · 2023
   Article
2. Human papilloma virus presence and its physical status in primary pterygium.Heliyon · 2023
   Article
3. Human papillomavirus infection and ocular surface disease (Review).International journal of oncology · 2019
   Review
4. human adenoviruses role in ophthalmic pterygium formation.Jundishapur journal of microbiology · 2015
   Article
5. Oxidant/antioxidant state in tissue of prymary and recurrent pterygium.BMC ophthalmology · 2014
   Article
6. Association of human papilloma virus with pterygia and ocular-surface squamous neoplasia.Eye (London, England) · 2012
   Review
7. Human papillomavirus and pterygium. Is the virus a risk factor?The British journal of ophthalmology · 2007
   Article

Corrections and comments

• Comment on
  Human papillomavirus in pterygium.2001

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as